Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR

详细信息    查看全文

• 作者：Ying Cai ; Qidi Wang ; Zhidong Ling ; Daniel Pipeleers ; Paul McDermott ; Mario Pende ; Harry Heimberg ; Mark Van de Casteele
• 关键词：Diabetes ; Beta cell ; Apoptosis ; AMPK ; Akt ; mTOR
• 刊名：Biochemical Pharmacology
• 出版年：2008
• 出版时间：15 May 2008
• 年：2008
• 卷：75
• 期：10
• 页码：1981-1993
• 全文大小：951 K

文摘

Sustained activation of AMP-activated protein kinase (AMPK) induces apoptosis in several cell types. In pancreatic beta cells this occurs under glucose limitation, or in the presence of the pharmacological AMPK activator 5-aminoimidazole-4-carboxamide-riboside (AICAR). It is unknown whether Akt activation can counteract AMPK-mediated apoptosis, nor whether mTOR activation downstream of Akt mediates any survival signal in these conditions. We report that expression of a constitutively active form of Akt increases mTOR activity and prevents apoptosis upon AMPK activation. Akt-mediated survival was inhibited by rapamycin. Expression of a constitutively active form of the mTOR target ribosomal protein S6 kinase (S6K) or of translation factor eIF4E reduced apoptosis by glucose limitation, and co-expression of S6K and eIF4E protected beta cells to the same extent as active Akt. The protective effects of active Akt and S6K were associated with increased cellular protein synthesis activity. It is concluded that Akt stimulation of mTOR and subsequent activation of the targets by which mTOR affects protein translation are required and sufficient mechanisms for Akt-mediated survival of beta cells undergoing sustained AMPK activation.